Liranaftate
Grundinformationen
- CAS
88678-31-3- Standard-SMILES
COc1cccc(N(C)C(=S)Oc2ccc3c(c2)CCCC3)n1- InChIKey
VPHPQNGOVQYUMG-UHFFFAOYSA-N- Summenformel
- C18H20N2O2S
- Durchschnittliche Molmasse
- 328,4 g/mol
- Monoisotopische Masse
- 328,12454906
Überblick
Liranaftate is a member of tetralins.
Namen und Bezeichner
- Bevorzugter Name
- Liranaftate
- IUPAC
- O-(5,6,7,8-tetrahydronaphthalen-2-yl) N-(6-methoxy-2-pyridinyl)-N-methylcarbamothioate
- Englischer Name
- Liranaftate
- Summenformel
- C18H20N2O2S
- Molmasse
- 328.43
Namen und Synonyme
Liranaftate88678-31-3LiranaftatoZefnartLiranaftatumM-732DTXSID60464705253IGO5X3DTXCID4026470RefChem:799366O-(5,6,7,8-tetrahydro-2-naphthyl)-6-methoxy-N-methylthio-2-pyridinecarbamate(6-Methoxy-2-pyridinyl)methylcarbamothioic acid O-(5,6,7,8-tetrahydro-2-naphthalenyl) ester
Weitere Namen anzeigen
LNFLIRANAFATELIANAFTATEPIRITETRATEphthalenyl)ester
834-254-6Liranaftate [INN]MFCD00865576Liranaftato [INN-Spanish]PiritetateO-(5,6,7,8-tetrahydronaphthalen-2-yl) (6-methoxypyridin-2-yl)(methyl)carbamothioateUNII-5253IGO5X3Piritetrate;M-732
Datenbank-Bezeichner
- CAS
88678-31-3- PubChem CID
- 3936
- DTXSID
DTXSID6046470- ChEMBL
CHEMBL1591365- ChEBI
CHEBI:31775
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 4,9
- Polarare Oberfläche (TPSA)
- 66,7 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 4
- Schwere Atome
- 23
- Formalladung
- 0
- Komplexität
- 406
Physikochemische Eigenschaften
- Schmelzpunkt
- 98.5 · 98.5-99.5°C
- Siedepunkt
- 462.5 · 462.5±55.0 °C(Predicted)
- Dichte
- 1.24 · 1.240±0.06 g/cm3(Predicted)
- storage temp.
- Keep in dark place,Sealed in dry,Room Temperature
- Löslichkeit
- DMSO (Slightly), Methanol (Slightly, Heated)
- Aggregatzustand
- Solid
- pka
- 1.24 · 1.24±0.10(Predicted)
- Farbe
- Off-White
- Merck
- 14 · 14,5515
- InChI
- InChI=1S/C18H20N2O2S/c1-20(16-8-5-9-17(19-16)21-2)18(23)22-15-11-10-13-6-3-4-7-14(13)12-15/h5,8-12H,3-4,6-7H2,1-2H3
- InChIKey
- VPHPQNGOVQYUMG-UHFFFAOYSA-N
- SMILES
- C(=S)(OC1=CC=C2C(=C1)CCCC2)N(C1=NC(OC)=CC=C1)C
Sicherheit und Regulatorisches
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
GHS-Klassifizierung
GHS Classification
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P272, P280, P302+P352, P305+P351+P338, P321, P332+P317, P333+P317, P337+P317, P362+P364, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Gefahrenhinweise
Hazard Classes and CategoriesSkin Irrit. 2 (100%)
Sicherheitsdaten
- hs_code
- 2933.39.4100
- RTECS-Nr.
- FD3890000
Chemie und Industrie
Pharmakologische Informationen
ATC Code
D - Dermatologicals
QD - Dermatologicals
Anwendungen
BeschreibungLiranaftate was launched in Japan as a new topical antifungal for the treatment of dermatophycoses. This compound belonging to the thiocarbamate class of antifungals can be prepared by condensation of 5,6，7,8-tetrahydro-2-naphthol with the corresponding Npyridylthiocarbamoyl chloride. It is a potent and specific inhibitor of squalene epoxidase and consequently a blocker of ergosterol biosynthesis in fungi, without any detectable effect on mammalian cholesterol biosynthesis in rat liver at therapeutic dose levels. Liranaftate was found to be significantly more active than the other thiocarbamate tolnaftate against several dermatophytes, including Trichophyton mentagrophyfes, and against certain yeasts, such as Crypfococcus neoformans. On the other hand, it was inactive against a variety of Gram-positive and negative bacteria. When applicated as a 1 or 2% cream during clinical trials, it was well tolerated and no systemic absorption was observed.
Anbieter100 Anbieter
北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
HubeiwidelychemicaltechnologyCo.,Ltd18627774460 · [email protected]
合肥翰刚医药科技有限公司+8618062405514 · [email protected]
Shanghai Yingrui Biopharma Co.,Ltd
Zugehörige Reaktionen
1
Notizen zur Verbindung
Wird geladen…